subject: Pharmaceutical Formulation To Fight Ovarian Cancer [print this page] The American Cancer Society reports that about 22,000 cases of ovarian cancer would be detected, of which about 80% of the cases would meet with fatal consequences! The staggering number of fatalities clearly indicates one thing Early diagnosis of ovarian cancer is a must and an effective treatment procedure, equally critical too.
Chemotherapy has often been spoken about, as a way to detect and cure ovarian cancer. That said, it is an expensive process, not to mention the hard ordeal patients have to go through during chemotherapy. The side effects of this treatment process, is something all the patients have to endure.
Pharmaceutical formulations like Gemzar from Eli Lily claim to work with Ovarian Cancer. It has been reported that individuals who had been on a dosage of Gemzar mentioned an increase in their survival period. That said, a meager reported increase of about 3 months in the survival period of patients coupled with the side effects in taking this drug has resulted in the FDA issuing several warnings to the company (Reports of a lawsuit being filed against the drug company are not entirely misleading too).
Other pharmaceutical formulations that can be used to cure ovarian cancer are Cisplatin, Carboplatin and Melphalan. Each of these formulations work, but they do have their set of side effects to contend with, which makes it highly difficult for patients to have a consistent drug that also delivers on the safety aspect.
The new OvaRex Mab technology promises to be an improvement over all the existing pharmaceutical formulations and chemotherapy, in a big way. This pharmaceutical formulation is an intravenous infusion of an antibody, which helps in curing ovarian cancer. The drug belongs to a class, monoclonal antibodies, which attaches to a specific antigen. In this case, the antibody attaches to the CA-125 antigen, thus resulting in a safe cure for the patient from ovarian cancer.
As on date, the Phase III trials for the working of this drug are in progress. If initial reports are to be believed, this drug seems to be a class cure for ovarian cancer, helping patients in a way that they dont have to deal with painful surgeries or excruciating chemotherapy procedures.
by: Jack
welcome to Insurances.net (https://www.insurances.net)
